The findings suggest that GITR, along with other immunosuppressive markers, plays a crucial role in mediating the effects of leptin on Treg function, ultimately influencing the balance between immune suppression and anti-tumor immunity in HCC [93]. The gene discussed is TNFRSF18; the disease is neoplasm.